How many 8-K filings has Agios Pharmaceuticals, Inc. filed?

Agios Pharmaceuticals, Inc. (AGIO) has 9 8-K (Current Event Report) filings on record, spanning Jan 2024 to Aug 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Agios Pharmaceuticals, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Agios Pharmaceuticals, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Agios Pharmaceuticals, Inc. (AGIO) — 8-K Filings

All 8-K filings from Agios Pharmaceuticals, Inc.. Browse 9 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (9)

Agios Pharmaceuticals Files 8-K — Aug 4, 2025 Risk: low
On August 4, 2025, Agios Pharmaceuticals, Inc. filed an 8-K report. The filing indicates a Regulation FD Disclosure, with no specific financial transactions or
Agios Pharmaceuticals Announces Board and Compensation Changes — Jul 8, 2025 Risk: medium
On July 3, 2025, Agios Pharmaceuticals, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing
Agios Pharmaceuticals Files 8-K: Officer Changes & Shareholder Votes — Jun 18, 2025 Risk: medium
On June 18, 2025, Agios Pharmaceuticals, Inc. filed an 8-K report detailing several key events. The filing includes information regarding the departure of direc
Agios Pharmaceuticals Announces Board and Compensation Changes — Feb 13, 2025 Risk: low
On February 10, 2025, Agios Pharmaceuticals, Inc. announced changes in its board of directors and executive compensation arrangements. The company filed an 8-K
Agios Pharmaceuticals Files 8-K Report — Jan 13, 2025 Risk: low
On January 13, 2025, Agios Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation F
Agios Pharmaceuticals Files 8-K Report — Jan 6, 2025 Risk: low
On January 3, 2025, Agios Pharmaceuticals, Inc. filed an 8-K report. The filing primarily serves as a current report and does not appear to disclose any specifi
Agios Pharmaceuticals Files 8-K on Shareholder Vote Matters — Jun 20, 2024 Risk: low
On June 20, 2024, Agios Pharmaceuticals, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not con
Agios Pharmaceuticals Files 8-K with Material Agreement — May 28, 2024 Risk: medium
On May 24, 2024, Agios Pharmaceuticals, Inc. entered into a Material Definitive Agreement. The company also reported on other events and filed financial stateme
Agios Pharma Files Routine 8-K for Regulatory Compliance — Jan 8, 2024
Agios Pharmaceuticals, Inc. filed an 8-K on January 8, 2024, indicating a routine filing for Regulation FD Disclosure and Financial Statements and Exhibits. Thi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX